Gene Query: ARHGAP8

Dataset Description Geneva Score
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression (nuclear RNA) 25.16
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 24.48
Identification of a unique subtype of lung squamous cell carcinoma defined by SOX2 and a neural differentiation factor BRN2 [RNA-seq] 24.48
RNA-seq analysis of BAP1-depleted uveal melanoma cells 19.63
Prostate Cancer Cell RNA-Seq (PC3E and GS689.Li) 17.5
RNA-seq analysis of Retinoic Acid and Non-treated Control hiPSCs 17.07
A pooled single-cell genetic screen identifies regulatory barriers in the continuum of the epithelial-to-mesenchymal transition 15.26
Identification of differential expressed genes of JQ1 or JQ1+Bortezomib in colorectal cancer cells 13.77
Regulation of cellular heterogeneity and rates of symmetric and asymmetric divisions in triple-negative breast cancer 13.2
RNAseq analysis of patient-derived luminal breast cancer xenografts treated with progestins 12.06
Patient-derived luminal breast cancer xenografts with progestins 12.06
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 11.89
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 11.89
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 11.68
Evolved Labels of Placental Invasion in Human and Bovine Endometrial Stroma 11.01
LED, a long non-coding RNA activator of enhancer RNAs, is hypermethylated in human cancers 10.86
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 10.78
Next Generation Sequencing Facilitates Quantitative Analysis of SW480 cells and HPSE-knockdown SW480 cells Transcriptomes 10.31
Chronic cadmium exposure decreases the dependency of MCF7 breast cancer cells on ERα 10.08
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 9.79
NR2F2 study 9.64
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 9.64
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 9.05
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 9.01
Reconstitution of the human pancreatic niche stimulates differentiation of hESCs into beta cells and reveals new signals for pancreatic endocrine cell maturation 8.74
Effect of Polybrominated diphenyl ethers (PBDEs) on gene expression of MCF7 cells 8.68
SIX4 acts as a master regulator of genes associated with the malignant phenotype of non-small cell lung cancer cells 8.61
Oncogenic Serine-Threonine Kinase Receptor Associated Protein Supports Hepatocellular Carcinoma Cell Growth by Enhancing Wnt/β-catenin Signaling 8.58
NAD+ Analog-sensitive PARPs Reveal a Role for PARP-1 in Transcription Elongation 8.22
Evidence for HOXC6 as a potential molecular marker for non-small cell lung cancer 8.07
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 7.8
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 7.75
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc [RNA-Seq] 7.45
A novel lncRNA lncRNA-AF339830 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 7.45
AKAP8 inhibits tumor metastasis by antagonizing EMT-associated RNA alternative splicing 7.38
mRNA and RNC-mRNA deep sequencing of three hepatocellular carcinoma cell lines 7.1
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells [RNA-seq] 6.95
Distinct Roles of BET Family Members in ERα Enhancer Function and Gene Regulation in Breast Cancer Cells 6.95
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 6.73
Silencing p300 in MCF7 cells to study expression and alternative splicing 6.59
Small-molecule-based Human Genome G4 Profiling Reveals Potential Gene Regulation Activity 6.12
A SIRT1-centered Circuitry Regulates Breast Cancer Stemness and Metastasis 5.68
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 5.65
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 5.65
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.64
Next Generation Sequencing Analysis of Colorectal Cancer Tissue Transcriptomes 5.63
LIN28A Over-expression RNAseq 5.63
POLR3G Dependent PolyA+ and smallRNA Transcriptomes in Human Pluripotent Stem Cells 5.46
Estrogen receptor and mTOR signaling rewires cancer metabolism in obesity-associated breast cancer 5.37
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 5.36
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.33
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome 5.13
S-adenosyl-methionine treatment selectively block liver cancer cell lines transformation and invasiveness by alterations of cancer- and invasion specific transcriptome and methylome (RNA-Seq) 5.13
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 5.03
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 5.03
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 4.94
Single Cell RNA-sequencing of cell types isolated by FACS from normal human prostates 4.89
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 4.81
IRF2 is a master regulator of human keratinocyte stem cell fate 4.81
Club cells surviving influenza A virus infection induce temporary non-specific anti-viral immunity 4.78
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 4.76
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.75
Epigenetic reprogramming at estrogen-receptor binding sites alters 3D chromatin landscape in endocrine resistant breast cancer 4.74
Epigenetic reprogramming at estrogen-receptor binding sites alters the 3D chromatin landscape in endocrine resistant breast cancer [RNA-seq] 4.74
Error-free and error-prone DNA repair gene expression through reprogramming and passage in human iPS cells 4.71
mRNAseq of Huntington's disease and control patient iPSC-derived brain microvascular endothelial cells 4.66
SAM68 is required for regulation of Pumilio by the NORAD long noncoding RNA 4.63
Expression profiles of cultured human epididymis cells reveal the functional diversity of caput, corpus and cauda regions. 4.63
Impact of DNA MMR activity on antiviral gene expression in H441 cells infected with influenza A virus 4.6
Gene expression profile in breast cancer cell lines using RNA sequencing 4.57
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 4.54
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [ESRP KD] 4.49
The lung-enriched p53 mutants V157F and R158L/P regulate a novel transcriptome in lung cancer 4.43
Modulation of gene transcription and epigenetics of colon carcinoma cells by bacterial membrane vesicles 4.41
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 4.32
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 4.29
miRNA-1343 attenuates pathways of fibrosis by targeting the TGF-beta receptors [RNA-seq] 4.21
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 4.16
Effect of nuclear IL-33 on gene expression 4.16
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 2) 4.12
Cell Type-Specific Chromatin Signatures Underline Regulatory DNA Elements in Human Induced Pluripotent Stem Cells and Somatic Cells 4.04
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 4.03
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 4.03
Gene expression profile in endometrial organoids cultured in normal follicular phase vs PCOS-like hormone profile 3.88
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 3.78
GCTM-5 positive and negative cells in pancreatic adenocarcinoma cell lines 3.76
Transcriptome analysis of VCaP xenografts resistant to dual therapy with abiraterone and enzalutamide 3.75
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition [RNA-seq] 3.74
Grainyhead-like 2 (GRHL2) and epigenetic remodeling in the intermediate states of epithelial-mesenchymal transition 3.74
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.72
Transcriptome analysis of kidney organoids 3.7
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1, H1 derived APLNR+ cells, CD31+CD34+ cells and CD43+ cells during human early hematopoietic differentiation 3.7
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 3.67
RAID allows multiplexed quantification of intracellular (phospho-)proteins and transcriptomes from fixed single cells 3.65
CDK12 catalytic activity is rate-limiting for RNAPII processivity on core DNA replication genes and G1/S progression 3.63
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 3.61
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development [set 1] 3.59
Effects of Polybrominated Diphenyl Ether (PBDE) Mixture on estrogen receptor positive (ER+) patient-derived tumor xenograft (PDX) model 3.57
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 3.53
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 3.52
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 3.52
Loss of Function Mutations in ETS2 Repressor Factor (ERF) Reveal a Balance Between Positive and Negative ETS Factors Controlling Prostate Oncogenesis [22PC RNA-seq] 3.47
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone 3.45
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [IMR90_MCF7_RNA-Seq] 3.45
Large-scale epigenetic reprogramming is punctuated late during the evolution of pancreatic cancer progression 3.44
RNA-seq of human aneuploid cell lines with Trisomy 21 3.41
Global gene expression profiling from LeuCAG3'tsRNA depleted- HeLa and HCT-116 cell lines through 50 base pair paired-end RNA-seq 3.4
RNA-seq of MCF10A cells and CAF 3.38
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 3.38
Enriched retinal ganglion cells derived from human embryonic stem cells (RNA-seq) 3.34
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 3.33
Targeted differentiation of regional ventral neuroprogenitors and related neuronal subtypes from human pluripotent stem cells 3.33
Total RNA sequencing of WT intestinal orgaonids. 3.32
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.27
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer 3.26
Somatic cell fusions reveal extensive heterogeneity in basal-like breast cancer [RNA-Seq] 3.26
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 3.25
RNA isoform screens reveal the essentiality and tumor suppressor activity of ultraconserved poison exons 3.22
Function of HNRNPC in breast cancer cells by controlling the dsRNA-induced interferon response 3.14
Endometrial transcriptome and PGR cistrome in cycling fertile women [RNA-seq] 3.1
Endometrial transcriptome and PGR cistrome in cycling fertile women 3.1
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 3.07
Global Regulation of Alternative Internal Exon Usage by mRNA 3' End Formation Factors [RNA-Seq] 3.06
Global Promotion of Alternative Internal Exon Usage by mRNA 3' End Formation Factors 3.06
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 3.05
iPSC-Derived Cholangiocytes 3.04
SMUG1 promotes telomere maintenance through telomerase RNA end-processing 3.04
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 3.04
Cell-to-cell variation in defective virus expression and effect on host response during influenza virus infection 3.03
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 3.02
Profiling of circular RNAs in gastric cancer tissues and adjacent normal tissues 3.01
Directed differentiation of human embryonic stem cells to corneal endothelial cell-like cells: A transcriptomic analysis 3.0
Differentially expressed genes during pancreatic bud differentiation in cellular aggregates 3.0
RNA-sequencing 2.99
Diarrhoeal mechanisms of the Campylobacter jejuni enteritis 2.99
Next Generation Sequencing Facilitates Quantitative Analysis of miR-29b-1 and miR-29a targets in tamoxifen-sensitive and tamoxifen-resistant human breast cancer cells 2.99
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 2.96
LncRNA-GAS5 negative regulation of YAP-target genes expression 2.92
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 2.92
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 2.9
RNA-Seq of cKIT+ sorted cells from 16-16.5 week old fetal testes and ovaries and RNA-Seq of TRA-1-60+ H1 hESCs 2.89
Patient Derived Xenograft for Delivery of Precision Medicine in Castrate Resistant Prostate Cancer 2.88
Identification of transcripts altered upon LIN-41 knockdown in human embryonic stem cells 2.87
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 2.87
Transcriptome of EBV-infected gastric cancer cell lines 2.83
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 2.81
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 2.81
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 2.79
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 2.79
Deep sequencing of transcript levels in pluripotent stem cells and their differentiated derivatives in all three germ layers 2.79
Global transcriptomic analyses of bronchial epithelial cells exposed to 5 ng/mL TGF-β1 and 10 nM Estrogen individually and in combination 2.79
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 2.73
The ARID1A tumor suppressor controls global transcription via pausing of RNA Polymerase II 2.73
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 2.71
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 2.71
Analysis of active enhancers and direct androgen receptor target genes in VCaP prostate cancer cells 2.65
TMED9-gated CNIH4 and TGFa signaling promotes pro-metastatic states in human primary colon cancer cells 2.62
Modeling the MYC-driven normal-to-tumour switch in breast cancer. 2.61
Epigenome regulation during epidermal lineage commitment 2.61
Cerebellar differentiation in Ataxia-Telangiectasia 2.6
RNA-sequencing analysis of human fibrolamellar hepatocellular carcinoma and 4 maturational stages of the human hepatobiliary system 2.59
CDK12 regulates alternative last exon mRNA splicing and promotes invasion of a breast cancer cell line 2.58
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 2.55
Identification of PRMT5-dependent genes in ESA+CD24lowCD44+ MCF7 cells 2.54
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.54
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 2.53
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 2.51
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HOM] 2.49
H1609088 Human RNA-Sequencing 2.49
Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma [RNA-Seq; normal samples] 2.48
RNA sequencing Facilitates Quantitative Analysis of luminal breast cancer cells and basal breast cancer cells Transcriptomes 2.47
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 2.46
Gene Expression of Breast Cancer Cell Lines Across Biomaterial Platforms 2.45
Divergent effects of eRF3 and Upf1 on the expression of uORF carrying mRNAs and ribosome protein genes 2.42
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 2.33
The Wnt/β-catenin-signaling pathway is modulated by androgen ablation therapy for advanced clinical prostate cancer and contributes to androgen independent cell growth 2.32
A high-throughput screening strategy identifies regulators of alternative splicing via interaction with RNA G-quadruplexes 2.29
RNA-seq analysis of melanoma and carcinoma cells expressing FOXQ1 2.28
A transcriptome dataset revealing the molecular features of breast cancer stem cells 2.26
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 2.25
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 2.25
RNA-seq of UGP2 mutant human embryonic stem cells and in vitro differentiated neural stem cells 2.25
Global analysis of alternative splicing regulated by RBM10 2.17
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 2.14
Whole transcriptome RNA sequencing of human cells after HCV infection (ML-1 thyroid cell line, primary thyrocytes and Huh7.5 hepatocyte cell line) 2.14
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.13
Effect of Hypoxia in Severe Preeclampsia through Epigenetic Regulation 2.12
Cis-SAGe fusion RNAs in transcription splicing factors knocking-down 293T cells 2.11
Determination of a comprehensive alternative splicing regulatory network and the combinatorial regulation by key factors during Epithelial-to-Mesenchymal Transition [RBM47 KD] 2.1
Reprogramming postnatal human epidermal keratinocytes toward functional neural crest fates 2.1
SHP2 Drives Adaptive Resistance to ERK Signaling Inhibition in Molecularly Defined Subsets of ERK-dependent Tumors 2.08
A myogenic double reporter human pluripotent stem cell line allows prospective isolation of skeletal muscle progenitors 2.06
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 2.06
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 2.06
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 2.05
Methylome, hydroxymethylome, and integrative transcriptome profiling in human CRC tissue and paired normal tissues 2.04
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.03
Runx1 stabilizes the mammary epithelial cell phenotype and prevents epithelial to mesenchymal transition 2.0
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells 1.99
Cell differentiation grade determines distinct FOXA2 contributions to the cis-regulatory networks of pancreatic cancer cells [RNA-seq] 1.99
RNA-Seq analysis of human colorectal cancer with liver metastasis 1.99
Transcriptome analysis of H9 hESC derived cerebral organoids 1.97
Postnatal lipids drive hepatocyte maturation 1.97
Transcriptome wide identification of Dicer binding in human and C. elegans reveals a variety of substrates 1.97
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.96
Preclinical model of obesity and ER-positive breast cancer 1.96
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 1.96
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 1.96
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.93
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.92
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 1.91
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 1.91
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 1.91
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 1.89
Molecular Criteria for Defining the Naive Human Pluripotent State 1.88
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 1.87
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 1.87
Transcriptional profiling of JEG3 cells with HLA-G ablation via deletion of Enhancer L 1.85
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 1.82
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 1.82
RNAseq of ribosomal fractionation to assess the effect of CBFB on translation regulation 1.8
Transcriptional changes after overexpression of proliferation drivers in human mammary epithelial cells. 1.8
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 1.79
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 1.78
Transcriptomic analyssis following EHMT1/2 inhibition 1.76
Enriched EWSR1 and EWS-FLI1 RNA-seq of HNRNPH1-silenced TC32 Ewing sarcoma and 293T human embryonic kidney cells. 1.76
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 1.74
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 1.74
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 1.74
The transcriptome effect of overexpressing EZH2 in MCF7 1.72
Accurate annotation of human protein-coding small open reading frames 1.72
Single-cell RNA sequencing-based CRISPRi screening resolves molecular drivers of early human endoderm development 1.71
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 1.71
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 1.71
Potent antitumor activity of Cabozantinib, a c-MET and VEGFR2 Inhibitor, in a Colorectal Cancer Patient-derived Tumor Explant Model 1.71
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq2] 1.71
A common cell state in Triple Negative Breast Cancers represents a druggable vulnerability 1.71
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.71
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.71
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 1.7
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 1.69
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression 1.69
Loss of CHD1 facilitates oncogenic hijacking of AR during cancer progression [RNA-seq] 1.69
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 1.68
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 1.68
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.67
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 1.67
Polycomb complexes associate with enhancers to promote oncogenic transcriptional programs in cancer 1.67
Mediator kinase inhibition further activates super-enhancer-associated genes in AML 1.66
Effect in HCT116 cells of 3hr cortistatin A treatment on gene expression. 1.66
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 1.66
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 1.65
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 1.65
Intrinsic histone acetyltransferase activity of BRD4 is responsible for nucleosome eviction and transcriptional activation 1.63
An optimization system for isolating and sequencing of single human colon cancer cells 1.63
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 1.63
Meta-organization of Translation Centers Revealed by Proximity Mapping of Endoplasmic Reticulum Ribosome Interactors 1.63
Co-regulation of splicing by Rbfox1 and hnRNP M 1.62
Co-regulation of splicing by Rbfox1 and hnRNP M [hnRNPM k-d+Rbfox1 RNA-Seq] 1.62
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [ChrRNA-seq] 1.6
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 1.59
Enhancing human kidney organoid differentiation from pluripotent stem cells with high-throughput automation 1.59
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 1.59
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 1.58
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 1.58
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.58
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 1.58
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 1.55
Modulation of nonsense-mediated decay by rapamycin 1.54
Nuclear import of the DSCAM-cytoplasmic domain drives signaling capable of inhibiting synapse formation 1.51
SNHG5 siRNA knock down in HCT116 cells 1.5
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 1.5
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 1.49
Tamoxifen Resistance in Breast Cancer is Regulated by the EZH2-ERa-GREB1 Transcriptional Axis 1.48
Diverse AR-V7 cistromes in castration-resistant prostate cancer are governed by HoxB13 1.46
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 1.46
Interphase condensins regulate ligand-depedent enhancer activation 1.46
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 1.46
RNA-seq of naive and primed ES cells 1.44
C9/ALS Human Embryonic Stem Cells and C9/ALS Induced Pluripotent Stem Cells 1.43
‘Naïve’ ESRRB+ iPSCs with the capacity for rapid neural differentiation 1.41
CD97 is a Critical Regulator of Acute Myeloid Leukemia Stem Cell Function 1.41
Neurofibromin is an Estrogen Receptor alpha Transcriptional Co-repressor in Breast cancer 1.41
RNA sequencing of CACO-2 cells incubated with bifidobacteria grown on human milk oligosaccharides. 1.41
Integrin signaling regulates YAP/TAZ to control skin homeostasis 1.4
3’ Uridylation Expands miRNA Target Repertoire 1.38
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression [RNA-Seq] 1.38
Targeting FOXA1-mediated repression of TGF-β signaling suppresses castration-resistant prostate cancer progression 1.38
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 1.37
Next generation sequencing of advanced non-castrate prostate cancer treated with docetaxel chemotherapy 1.37
Role of SUMOylation in differential ERα transcriptional repression by SERMs and pure antiestrogens in breast cancer cells 1.37
Cellular recruitment by podocyte-derived pro-migratory factors in assembly of the human renal filter 1.37
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 1.34
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 1.34
Pharmacological Induction of a Progenitor State for the Efficient Expansion of Primary Human Hepatocytes 1.34
Expression data from fresh human embryonic lung epithelial tip and stalk cells and cultured organoids derived from tip and stalk. 1.31
Gene expression analysis of human adenomas. 1.3
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 1.3
Gene expression profile of human placenta from T. Cruzi infected mothers 1.28
RNA sequencing of human pancreatic cancer cell lines 1.26
Transcriptome of human keratinocytes with or without HPV16 oncogene expression 1.24
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 1.21
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 1.2
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.18
Obstructed defecation – an enteric neuropathy? An exploratory study of patient samples 1.17
Combined inhibition of STAT3 and DNA repair in palbociclib-resistant ER-positive breast cancer 1.17
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 1.16
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 1.16
Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain [Single Cell RNAseq] 1.16
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling 1.14
Long-term in vitro expansion of epithelial stem cells enabled by pharmacological inhibition of PAK1-ROCK-Myosin II and TGF-β signaling (RNA-seq) 1.14
Searching for target genes of miR-508/509/506/514 in HCT116 cells 1.14
Identification of long noncoding RNAs regulated by p53 1.13
Patient-derived xenograft platform for metastatic melanoma 1.11
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 1.07
Fixed tissue ChIP-Seq (FiT-Seq) of archived clinical samples reveals chromatin dynamics and tumor-specific enhancer profiles 1.07
IKZF1 as a Master Regulator of Immune Infiltrate Recruitment in Solid Tumors 1.06
Interaction between mitoNEET and NAF-1 in cancer cells 1.06
RNA-seq profiling identifies Androgen Receptor-regulated genes in prostate cancer cells 1.05
Androgen Receptor-regulated genes in prostate cancer cells 1.05
Recovery and analysis of nascent RNA 1.04
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.04
Genomic profiling of biliary tract cancer cell lines reveals molecular subtypes and actionable drug targets 1.04
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [BAA] 1.03
Global loss of epigenetic and transcriptional fidility defines a subclass of cancer with immunotherapy resistance 1.03
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques 1.02
Whole transcriptome splicing analysis in isogenic lung epithelial and adenocarcinoma cell lines with or without a recurrent splicing factor mutation, U2AF1 (S34F) 1.02
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 1.02
mRNA-sequencing of 293T-no dice transfected with miR-16, miR-214, or KSHV-miR-K6-5p 1.01
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 0.97
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 0.96
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 0.96
Transcriptome sequencing analysis of BRAF-mutant melanoma metastases. 0.96
Genome-wide maps of chromatin state and Gene Expression Profiling in HCT116 cells 0.95
Gene Expression Profiling of WT and KDM3A Knocked out Cell 0.95
Ex vivo expanded human 3D Nephrospheres engraft long term and repair chronic renal injury in mice 0.95
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.94
Effect of BB608 on Gene Expression in HNSCC Cell Line 0.93
Effect of PBK knockdown on C4-2 cell transcriptome 0.93
RNA sequencing reveals levamisole target genes PTPRZ1 and MDK and their links to interferon pathway in human podocytes 0.92
RNA-seq data corresponding to: AZD4573 is a highly selective CDK9 inhibitor that suppresses Mcl-1 and induces apoptosis in hematological cancer cells 0.92
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.92
Inhibition of ERG Activity in Patient Derived Prostate Cancer Xenografts using the Small Molecule Inhibitor YK-4-279 0.92
Profiling gene expression changes in ovarian cancer cells seeded on 3D organotypic culture of omentum 0.91
Functional Importance of eRNAs for Estrogen-dependent Gene Transcriptional Activation 0.91
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.9
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.9
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.89
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 0.87
Combined Genome and Transcriptome Sequencing to Identify Allelic Selection in Epithelial Ovarian Cancer 0.87
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 0.86
Disease-associated mutation in SRSF2 misregulates splicing by altering RNA binding affinities 0.85
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 0.85
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 0.85
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 0.84
BASP1 modifies the Tamoxifen response 0.84
RNAseq analysis of ESRP regulated splicing events in prostate cancer 0.81
TALEN-based knockout of mir-141 and mir-200c in SK-BR-3 cells 0.81
Expression profiling by RNA-Seq of breast cancer samples from patients in walnut-consuming and control groups 0.79
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.78
Profiling of escape kinetics of viruses subjected to RNAi 0.77
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 0.76
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 0.75
Gene expression patterns define the hepatocyte-like cells derived by different strategies 0.73
Gene expression patterns define the hepatocyte-like cells derived by different strategies [RNA-seq] 0.73
The gene expression profiles of gallbladder cancer 0.69
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.69
ENCODE Cold Spring Harbor Labs Long RNA-seq 0.69
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 0.69
Gene expression profiling in metabolically heterogeneous human lung tumors 0.68
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 0.66
The expression profiles of GBC liver metastasis 0.66
Fusion discovery in breast cancer cell line 0.65
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.63
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 0.61
RNA-seq in HT-29 colorectal cancer cells after F. nucleatum treatment 0.61
The effect of insulin on mRNA transcription of human pluripotent stem cells 0.6
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 0.6
Transcriptome sequencing after MAGOHB knockdown in MAGOH-deleted or non-deleted cancer cells 0.59
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 0.59
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability 0.58
The NORAD lncRNA assembles a topoisomerase complex critical for genome stability [RNA-seq] 0.58
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 0.57
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 0.57
Estrogen deprivation triggers and immunosuppressive phenotype in breast cancer cells 0.56
The lipodystrophic hotspot lamin A p.R482W mutation deregulates the mesodermal inducer T/Brachyury and early vascular differentiation gene networks 0.56
SREBP1 drives Keratin 80-dependent cytoskeletal changes and invasive behavior in endocrine resistant ERα breast cancer 0.56
RNA seq analysis of human Fetal and adult derived Enterospheres 0.55
GRHL2 is a key lineage determining factor which collaborates with FOXA1 to establish a targetable collateral pathway in the setting of endocrine therapy-resistant breast cancer (RNA-Seq data set 1) 0.53
The MEF2B Regulatory Network 0.52
The MEF2B Regulatory Network - RNA-seq data 0.52
Evaluating and comparing the Transcriptome of (human) Hek 293 based cells, expressing either CHD3 or CHD4 0.51
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.51
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.5
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 0.49
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 0.48
Gene expression alterations of pancreatic intraepithlial neoplasia 0.48
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.48
TrapSeq: An RNA Sequencing-based pipeline for the identification of genetrap insertions in mammalian cells 0.48
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes: Singapore Cohort RNA-seq 0.48
A Low-cost Multiplex Biomarker Assay Stratifies Colorectal Cancer Patient Samples into Clinically-relevant Subtypes 0.48
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.47
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.47
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.46
Human Embryoid Body Transcriptomes Reveal Maturation Differences Influenced by Size and Formation in Custom Microarrays 0.46
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 0.46
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 0.46
The phosphatidylinositol 3-kinase pathway as a potential therapeutic target in bladder cancer 0.44
Defective transcription elongation in a subset of cancers confers immunotherapy resistance (human cell lines RNA-Seq) 0.43
Kidney organoid reproducibility across multiple human iPSC lines and diminished off target cells after transplantation revealed by single cell transcriptomics 0.43
Gene expression analysis upon mtDNA depletion [RNA-seq] 0.43
Gene expression analysis upon mtDNA depletion 0.43
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 0.42
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq Cell lines] 0.41
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 0.4
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 0.4
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 0.39
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 0.39
Patient-derived xenograft models of non-small cell lung cancer for evaluating targeted drug sensitivity and resistance 0.39
SEUSS: A scalable screening platform to assess transcriptomic and fitness effects of transcription factor overexpression 0.39
Human Adult Sorted Live Cell Erythroblasts RNA-Seq. 0.38
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 0.37
Transcriptomic profiling of sequential tumours from breast cancer patients provides a global view of metastatic expression changes following endocrine therapy 0.36
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells 0.34
TNFα Signaling Exposes Latent Estrogen Receptor Binding Sites in Breast Cancer Cells [GRO-seq] 0.34
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 0.34
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches 0.34
Unlocking the transcriptomic potential of formalin-fixed paraffin embedded clinical tissues: Comparison of gene expression profiling approaches [RNA-Seq] 0.34
RNA sequencing of prostate cancers reveal insights on the prognostic significance of visibility on multi-parametric MRI 0.33
Next Generation Sequencing Facilitates Quantitative Analysis of UVB(20mJ/cm2 and 40mJ/cm2) exposed and untreated HaCaT keratinocytes Transcriptomes 0.33
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.31
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.31
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.31
Finding missing proteins from epigenetically manipulated human cells 0.3
Analysis of transcriptional differences after IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.3
Transcriptional analysis of ZIKV-infected Ifnar-/- and Ifnar+/- placentas and IFN-beta (IFN-b) or IFN-lambda (IFN-l) treated human mid-gestation chorionic villus explants 0.3
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 0.29
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine [RNA-Seq] 0.29
Expression data for HT29 cells treated with 5-aza-deoxy-cytidine 0.29
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 0.29
MRTF activates TEAD-YAP target gene expression 0.29
The global transcriptome analysis in the time course of hESC-derived cardiac differentiation 0.27
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma 0.27
Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma [RNA-seq] 0.27
Maternal-biased H3K27me3 correlates with paternal-specific gene expression in the human morula 0.26
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 0.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.25
RNA sequencing of CACO-2 cells incubated with Bifidobacteria breve grown on human milk oligosaccharides. 0.25
Reprogramming of Tumor-infiltrating Immune Cells in Early Stage of NSCLC 0.24
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 0.24
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.24
RNA-Seq analysis of Head and Neck Squamous cell carcinoma cell-lines 0.23
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.22
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 0.22
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 0.21
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 0.2
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 0.2
RNAseq analysis of ruxolitinib treated breast cancers 0.2
Sex-specific gene expression differences are evident in human embryonic stem cells and during in vitro differentiation of human placental progenitor cells 0.19
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 0.17
Neonatal and adult human testis defined at the single-cell level 0.17
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 0.16
Gene expression profiling of papillary thyroid cancer from central and invasive regions 0.16
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.16
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.16
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.15
Illumina HiSeq Sequencing on Breast cancer PDX samples 0.14
LncRNA DEANR1 facilitates human endoderm differentiation by activating FOXA2 expression 0.14
Downregulation of LATS kinases alters p53 to promote cell migration 0.14
Silencing SPIB in attached and floating state of H1703 lung cancer cells 0.13
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 0.12
Epigenome regulation during epidermal lineage commitment [RNA-seq] 0.11
Propargite, an environmental chemical, interacts with GWAS identified diabetes genes to impact human pancreatic β-cell death 0.1
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.1
mRNA differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.1
Differential expression in LNCaP cells expressing the wild-type androgen receptor (AR-WT) or the ligand-independent AR-V7 splice variant 0.1
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.1
Genome-wide effect of inhibition of glutamine transporter ASCT2 in PC-3 cells by BenSer or GPNA 0.09
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer 0.09
The Chromatin-Looping Factor ZNF143 Engages at Looping Promoters to Favor the Estrogen Response in Breast Cancer (RNA-seq) 0.09
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.08
Altered mRNA splicing by mutant p53 activates oncogenic RAS in pancreatic cancer 0.08
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.07
Activating Transcription Factor 4 modulated TGFb-induced aggresiveness in triple negative breast cancer vis SMAD2/3/4 and mTORC2 signaling 0.07
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 0.07
Deep RNA sequencing of the human placental transcriptome 0.06
Energy Metabolism during Anchorage-Independence 0.05
Noncoding regions are the main source of targetable tumor-specific antigens 0.05
Transcriptomic Analysis Of circRNAs/miRNAs/mRNAs upon Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection 0.05
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 0.04
Retinoic acid suppresses MYB in adenoid cystic carcinoma 0.04
RNA-Seq analysis of cSCC cells followed by siRNA-induced gene knockdown of C1s. 0.03
The circadian transcriptional landscape in primary human mammary epithelial cells 0.02
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.02
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 0.01
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.01
Gene expression analysis of breast cancer cell-lines 0.01
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.01
Single-cell Transcriptomics reveals multi-step adaptations to endocrine therapy 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation